Dimensional Fund Advisors LP Arcutis Biotherapeutics, Inc. Transaction History

Dimensional Fund Advisors LP

  • $403 Billion
  • Q3 2024

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 07, 2024
SELL
$1.84 - $4.82 $15,950 - $41,784
-8,669 Reduced 6.81%
118,608 $383,000
Q3 2023

Nov 09, 2023
SELL
$5.31 - $10.98 $81,359 - $168,235
-15,322 Reduced 10.74%
127,277 $675,000
Q2 2023

Aug 09, 2023
SELL
$7.51 - $15.0 $2.22 Million - $4.43 Million
-295,516 Reduced 67.45%
142,599 $1.36 Million
Q1 2023

May 12, 2023
BUY
$10.23 - $17.14 $691,803 - $1.16 Million
67,625 Added 18.25%
438,115 $4.82 Million
Q4 2022

Feb 09, 2023
BUY
$13.96 - $20.4 $789,396 - $1.15 Million
56,547 Added 18.01%
370,490 $5.48 Million
Q3 2022

Nov 10, 2022
BUY
$17.85 - $26.95 $23,829 - $35,978
1,335 Added 0.43%
313,943 $6 Million
Q2 2022

Aug 12, 2022
BUY
$16.33 - $22.2 $1.39 Million - $1.89 Million
85,225 Added 37.48%
312,608 $6.66 Million
Q1 2022

May 13, 2022
BUY
$14.38 - $22.79 $1.49 Million - $2.36 Million
103,477 Added 83.51%
227,383 $4.38 Million
Q4 2021

Feb 09, 2022
BUY
$14.98 - $25.5 $666,774 - $1.14 Million
44,511 Added 56.06%
123,906 $2.57 Million
Q3 2021

Nov 12, 2021
BUY
$19.28 - $27.1 $628,836 - $883,893
32,616 Added 69.72%
79,395 $1.89 Million
Q2 2021

Aug 12, 2021
BUY
$24.42 - $34.75 $1.14 Million - $1.63 Million
46,779 New
46,779 $1.28 Million

Others Institutions Holding ARQT

# of Institutions
197
Shares Held
129M
Call Options Held
738K
Put Options Held
82K
View Full List

About Arcutis Biotherapeutics, Inc.

ARQT Quotes by TradingView
  • Ticker ARQT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 60,187,500
  • Market Cap $825M
  • Description
  • Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. Its lead product candidate is ARQ-151, a topical roflumilast cream that has completed Phase III clinical trials for the treatment of plaque psoriasis and atopic dermatitis. The company is also developing A...
More about ARQT
Track This Portfolio

Track Dimensional Fund Advisors LP Portfolio

Follow Dimensional Fund Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Dimensional Fund Advisors LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email